| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |